Nu Skin Projects 20%-24% Growth In Q1 Despite China Regulatory Probe
This article was originally published in The Rose Sheet
Executive Summary
Analysts have faith in Nu Skin’s strategy, and future prospects, as it works with Chinese officials to resolve an investigation into its business practices in China. While the firm’s recent explosive growth is expected to fall off substantially in the first quarter of fiscal 2014 – to a more modest 20% to 24% – Nu Skin is confident that the steps it is taking in China “will make our long-term success more likely.”